Efavirenz Likely Safe for Pregnant HIV-positive Women Efavirenz Likely Safe for Pregnant HIV-positive Women

The prevalence of birth defects following use of efavirenz (EVF)-based antiretroviral therapy (ART) is not statistically different from non-EFV-based ART during conception or in the first trimester, researchers say.Reuters Health Information

Source: Medscape Medical News Headlines - January 2, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news